Find-Speaker.com




4th Human Abuse Liability and Abuse-Deterrent Formulations (description)

""

Category:Health & Wellness
Address:Hyatt Regency Bethesda, One Bethesda Metro Center Bethesda, Maryland, United States of America 20814
Phone:917-258-5158
Event dates:11/6/2017 - 11/7/2017 (This event has already taken place)
Event web site:http://go.evvnt.com/142749-1
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 4th Human Abuse Liability and Abuse-Deterrent Formulations

Speakers/Presenters:

Topics to be Covered:

  • David Baker, Peter Pitts, Angela DeVeaugh-Geiss, Lynn Webster, deirdre hall, Beatrice Setnik, Richard Dart, Joseph Stauffer, Aaron Graham, Karsten Lindhardt, Torben Elhauge, Michael Barnes, Graham Wood, Gene Levinstein, William Schmidt, Colville Brown, Daniel Cohen, Marta Sokolowska, Jeremy Adler, John Burke
  • Science, Health and Medicine
Contact:amagnolo@exlpharma.com
Organizer phone:
Offering type:Data not provided
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:ExL Events
Est. # of exhibitors:
Currency:US Dollars
Language:Data not provided
CE Credits:
Organizer URL

Description:

For the first time, drug overdoses have become the greatest cause of mortality for people under 50 in the United States. The opioid addiction crisis is rising out of control and leading to an increase in political and market pressure on drug companies from regulators, legislators, insurers, physicians, and patient advocacy groups. New FDA final guidelines for branded opioids were released at the beginning of 2017, and the final guidelines for generics are expected by the end of the year. How you prepare for and respond to them will shape the future of your company’s regulatory compliance and market success.

ExL’s 4th Human Abuse Liability and Abuse-Deterrent Formulations conference is the largest industry event specifically focused on the full spectrum of challenges and goals required to create and market drugs with lowered abuse potential. No other event goes into as much detail about preclinical development of abuse-deterrent drugs and delivery mechanisms, clinical trial design, and building strong, reliable networks with every stakeholder throughout the regulatory and market access community.

Schedule:

Time: 8:00 am to 5:00 pm

Registration Fee Details:

Conference Only - Register by September 22, 2017: USD 1995,
Conference + Dinner - Register by September 22, 2017: USD 2395,
Conference Only - Register after September 22, 2017: USD 2195,
Conference + Dinner - Register after September 22, 2017: USD 2595

Other items that tuition includes:

Travel and hotel arrangements:

 
 
Contact Person:Andrea
TitleMagnolo
Contact Emailamagnolo@exlpharma.com
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Structural makeupData not provided
Host Sponsor; Other SponsorsExL Events
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Range:
Number in attendance of:
Range:
Target BoundariesLocal
Is Registration contact information the same as Organizer Contact above?Yes
Web Page go.evvnt.com/142749-0
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
FAQ
Contact Us